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ABSTRACT
Anaplastic large cell lymphoma (ALCL), a well-recognized entity, presents a 
varied clinical picture and epidemiological characteristics associated with the 
expression of the anaplastic lymphoma kinase (ALK) protein. When classic 
symptoms are present (weight loss, fever, and night sweats) and combine with 
enlarged and easily accessible peripheral lymph nodes, diagnosis is not that 
difficult. But when the clinical presentation is nonspecific, a tough diagnostic 
task is required. HIV infection is highly associated with neoplastic disorders—
mainly with those of hematological origin. However, ALCL is exceptionally 
associated with HIV infection, and the few reported cases are ALK– ALCL. The 
authors report two cases of ALK+ ALCL with the unusual clinical presentation: 
one is associated with the HIV infection and the other presents as a fever of 
unknown origin (FUO) without peripheral lymphadenopathy. The latter was 
autopsied and was characterized by nodal and extra nodal involvement. The 
authors call attention to the plurality of clinical presentation of this group of 
lymphomas, and the early indication of bone marrow examination in cases of 
an FUO with elevated hepatic enzymes and lactic dehydrogenase.
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CASE 1
A 34-year-old female patient sought the 
medical facility complaining of a painful and 
progressive-growing mass in the left groin during 
the preceding 2 months. Fever and diaphoresis 
supervened during the last month concomitantly 
with 5 kg of weight loss. Her past medical history 
included the diagnosis of HIV infection since the last 
pregnancy 4 years ago, but under medical advice 
discontinued anti-retroviral therapy. The physical 
examination revealed a well-looking patient with 
normal hemodynamic parameters, afebrile, with a 
tender mass localized in the left groin measuring 
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atypical, cohesive neoplastic cells, sometimes with 
multinucleation in a horseshoe pattern (“hallmark 
cells”). The immunohistochemical study showed 
positivity for CD45, CD30 (membranous and dot 
pattern), CD5, and anaplastic lymphoma kinase 
(ALK)-1, while CD20, CD3, Epstein–Barr virus 
(EBV), AE1/AE3 were negative. The proliferation 
rate, evaluated by Ki67, was positive in 99% of the 
neoplastic cell population (Figure 1).
The unilateral bone marrow biopsy was 
normal without neoplastic infiltration. The final 
diagnosis was ALK+ ALCL in an HIV-positive 
patient, with B symptoms, Ann Arborg stage IIXSB. 
The patient was referred to an oncological center 
for chemotherapy and restarted highly active 
antiretroviral therapy (HAART). She received, at 
first, a COP cytoreductive regimen, followed by 
CHOP regimen for eight cycles with complete 
remission. However, 12 months later, she presented 
a recurrence of the disease, confirmed by a cervical 
g Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report 
of the Committee on Hodgkin’s Disease Staging Classification. Cancer 
Res. 1971;31(11):1860-1.
10 cm at the longest axis, corresponding to 
adhered and hardened lymph nodes conglomerate, 
accompanied by unilateral left lower limb edema. 
Laboratory workup disclosed normal renal function, 
mild elevation of ALT, AST, and LDHe, peripheral 
blood count with mild leukopenia and lymphopenia. 
The CRPf was slightly increased and the CD4 count 
was less than 50 cell/mm3. Ultrasound Doppler of 
the left groin showed enlarged lymphadenopathy, 
with lymph nodes measuring up to 7.9 × 2.6 cm with 
signs of central necrosis. Deep venous thrombosis 
was ruled out. Abdominal computed tomography 
(CT) showed mesenteric, retroperitoneal lympha-
denopathy, along with left external iliac artery, and 
left inguinal region lymphadenopathy. Thoracic 
and neck CT did not show significant involvement 
of the lymphatic chains. An inguinal lymph node 
was biopsied; the histological examination of 
which revealed a partially involved lymph node 
with distended sinuses by the presence of large, 
e ALT = alanine aminotransferase, AST = aspartate aminotransferase, 
LDH = lactate dehydrogenase.
f CRP = C-reactive protein.
Figure 1 – Photomicrography of the lymph node. A – Presence of large, atypical, sometimes multinucleated 
neoplastic cells (HE, 100X); B – CD30 positive, note the lymph node sinusoidal pattern infiltration (IH, 40X); 
C – ALK protein positivity (IH, 10X); D – High proliferation rate showed by Ki67 (IH, 10X).
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CASE 2
A 20-year-old male patient sought the 
emergency unit complaining of high-grade fever 
and chills accompanied by malaise, headache, and 
weakness during the last 10 days. He referred loss 
of appetite and consequently 3 kg of weight loss (5% 
of total body weight). His physical examination was 
normal, as well as the ophthalmoscopy. Laboratory 
workup showed normal renal function, glucose 
determination, electrolytes, hepatic enzymes, liver 
function tests, protein electrophoresis, and urinalysis. 
Serology for HIV, hepatitis B and C, toxoplasmosis, 
EBV, syphilis, leptospirosis, and dengue fever were 
negative. Rubella and cytomegalovirus serologies 
showed IgG positive but IgM negative. Tests for 
antinuclear antibody, anti-neutrophil cytoplasmic 
antibody, and rheumatoid factor were also negative. 
The tuberculin skin test was negative as well as the 
acid-fast bacilli research in the sputum. The thoracic 
CT was normal and echodoppler of the lower limbs 
lymph node biopsy, even though she was on 
HAART and the CD4 cell count was 666 cells/mm3. 
At this time, the lymphadenopathy involved the 
cervical, supraclavicular, axillary, mesenteric, and 
retroperitoneal regions. Treatment was reinitiated 
in accordance with the Ian Magrathh regimen 
(cyclophosphamide, methotrexate, and intrathecal 
cytarabine and methotrexate) for 3 cycles followed 
by an autologous bone marrow transplant for 
consolidation. During all the oncological treatment 
until the last followup consultation, the patient was 
taking HAART (lamivudine, lopinavir, ritonavir, and 
tenofovir). She has been free of relapse for the past 
3 years.
h Magrath IT, Shad AT, Sandlund JT. Lymphoproliferative disorders in im-
munocompromised individuals. In: Magrath IT, editor. The non-hodgkin’s 
lymphomas. 2nd ed. London: Oxford University Press, 1997. p. 955-74.
Figure 2 – Photomicrography of the bone marrow. A – (HE, 10X); and B – (HE, 100X) showing infiltration 
by large, atypical, neoplastic cells, with some multinucleated cells in a horseshoe pattern (“hallmark cells”); 
C – Immunohistochemistry positivity for CD-30 (100X); D – Immunohistochemistry positivity for ALK protein 
(100X).
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the bone marrow biopsy was not prioritized over the 
other examinations, being undertaken lately in the 
course of the disease. The diagnosis was confirmed 
by the immunohistochemical report, which showed 
a profile consistent with ALK+ ALCL: (positive for 
CD30, ALK, and EMA, and negative for CD20, CD3, 
CD15, CD43, CD34, CD31, and myeloperoxidase) 
(Figure 2).
The autopsy revealed generalized 
lymphadenopathy (lymph nodes measuring up to 2 
cm) involving the axillary, mediastinal, abdominal, 
and lower limb chains, which showed sinusoidal 
infiltration by large, atypical multinucleated cells 
(Figure 3).
The lungs, liver, and spleen also showed 
lymphomatous infiltration (Figure 4). The final 
diagnosis was ALK+ ALCL and the immediate cause 
of death was septic shock with massive bilateral 
pulmonary hemorrhage.
DISCUSSION
In 1985, Stein et al.1 first described ALCL 
and since then its definition has greatly evolved. 
Nowadays, this lymphoma is fairly well characterized 
and currently recognized by the WHO2,3 as a defined 
entity. ALCL is characterized by a proliferation of 
large lymphoid cells with distinctive morphology: 
hallmark cells, marked sinus and perivascular 
growth (angiocentrism) pattern, a strong expression 
of CD30, and cytotoxic granules protein, expressing 
(or not) the ALK protein. This lymphoma comprises 
approximately 3% of adult and 10–30% of childhood 
ruled out the diagnosis of deep venous thrombosis. 
The cerebrospinal fluid (CSF) examination was 
normal. Four sets of blood samples, urine, and CSF 
cultures were negative for bacteria, fungus, and 
acid-fast bacilli. The patient remained hospitalized 
presenting a daily temperature of 38.5 °C and 39 °C 
and was recorded as a fever of unknown origin (FUO). 
In this setting, he underwent a transesophageal 
echodopplercardiogram, which was normal. The 
determination of a high titer of ferritin was odd, 
which was interpreted as an inflammatory marker or 
even the possibility of Still’s disease, without other 
diagnostic criteria. The abdominal ultrasound and 
CT were normal despite the progressive raising 
determination of liver enzymes (AST, ALT, APh and 
γGT) and LDHi. Nevertheless he was submitted to a 
wedge liver biopsy through laparoscopy, which did 
not detect any abnormality in the abdominal cavity. 
The histological examination of the liver specimen 
showed non-specific findings: preserved lobular 
architecture, with moderate neutrophilic infiltration 
of portal tract with histiocytes, mild biliary ductal 
proliferation. The hepatocytes, Kupfer cells, as well 
as the central veins were also preserved. Bone 
marrow aspiration resulted in dry tap, which was 
followed by a bone marrow biopsy, which showed 
hypoplasia of the all hematopoietic series and focal 
infiltration by large lymphoid cells, with nuclear 
pleomorphism, atypia and evident nucleoli.
The patient evolved with lower limb cellulitis 
and septic shock, and died before the complete 
diagnostic work up has been completed. Unfortunately 
i ALT = alanine transaminase; APh = alkaline phosphatase; AST = 
aspartate transaminase; γGT = gamma glutamyl transferase; LDH = 
lactate dehydrogenase.
Figure 3 – Photomicrography of the lymph node. A – Effacement of the original architecture due to sinusoidal 
infiltration by large atypical multinucleated cells (HE, 100X); B – Immunohistochemistry positivity for CD30 
(HE, 400X).
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observed with the incidence ranging between 22% 
and 28%.5,11,12
Until the report of Perez et al. in 2010,13 
37 cases of HIV-infected ALCL cases were 
identified. In the English literature in 2012, this 
number did not exceed 50 cases.8,14 These cases 
were characterized by the involvement of a 
young population (mean age 38 years), with male 
predominance (M:F = 4:1), a median CD4 count of 
83 cell/mm3, a rare expression of the ALK protein, 
an exclusive extranodal presentation, and a very 
aggressive clinical course with the median overall 
survival of 5 months.8,12,13 Case 1, reported herein, 
calls attention to its unusual presentation: it affected 
a female patient; it presented as an inguinal bulky 
disease along with lymph node enlargement of the 
iliac and periaortic chains; there was no clinical or 
radiological evidence of extra nodal disease; there 
was a positive expression of the ALK protein; and a 
non-fatal outcome.
In a study conducted by Mosunjac et al.6 5 
cases of ALCL in a series of 23 presented clinically 
as an FUO. In this series beyond fever, other 
symptoms were nonspecific and the duration ranged 
from 1 week to 3 months. Among the laboratory 
findings, attention was called to leukocytosis with 
neutrophilia, thrombocytopenia, and abnormal 
coagulation tests. Lactic acidosis, elevated hepatic 
enzymes, APh, and LDH were present in 80% of 
the cases. Only one case showed large pre- and 
retrosternal masses misinterpreted as scar tissue 
of a previous coronary bypass grafting. All five 
cases were autopsied and the major findings were 
compatible with extranodal involvement of ALCL, and 
non-Hodgkin lymphomas (NHLs).4,5 Chromosomal 
translocations, such as t(2; 5)(p23; q35), t(1; 2)(p21; 
q23), t(2; 3)(p23; q21) and t(2; 17)(p23; q23), are 
responsible for the expression of the ALK protein, 
which apparently is associated with younger patients 
and a better prognosis.
Therefore, ALCL is divided into three groups, 
namely: ALCL-ALK+, ALCL-ALK- and cutaneous 
ALCL. Disregarding the cutaneous group, this 
lymphoma may present clinically as a localized 
as much as extranodal widespread disease in 
non-HIV-infected individuals. Unusual clinical 
presentation, including fever, multiple organ failure, 
shock, and adrenal insufficiency can be associated 
with subtypes of ALCL, particularly in cases of 
extranodal involvement.6,7 This heterogeneous 
clinical presentation challenges the clinician and 
may be responsible for a considerably delayed 
diagnosis.
Although it is decreasing in the era of HAART, 
the association of HIV infection and the development 
of various malignancies still remains high when 
compared with the general population.8,9 In this 
setting, B-cell NHLs are more frequently reported, 
unlike T-cell lymphomas, which account for 1.4% 
of 6,788 lymphomas in a population of 302,834 
persons with AIDS. Although rare, the relative risk 
of T-cell lymphoma, estimated by standardized 
incidence ratio, was 15.0 (95% confidence interval: 
10.0-21.7).10 In another study, the incidence of 
T-cell lymphoma was 2.6% in a series of 429 AIDS-
related lymphomas.5 Among the T-cell lymphomas 
in the AIDS population, ALCL is even more rarely 
Figure 4 – A – Photomicrography of the liver showing microscopic and multifocal infiltration of the portal 
tract by large atypical multinucleated cells (HE, 400X); B – Photomicrography of the lung showing focal 
infiltration of large atypical multinucleated cells in the parenchyma and perivascular. Note hemorrhagic foci 
and organizing pneumonia (HE, 100X).
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CONCLUSION
Even though ALCL is a well-defined entity, 
this neoplasia presents a plurality of clinical 
pictures, and has to be considered among HIV-
infected patients and those with the diagnosis of an 
FUO. In the latter group of patients, we recommend 
early biopsy of the bone marrow if no peripheral and 
accessible lymph node is present, mainly in those 
cases where the LDH and hepatic enzymes are 
unexpectedly increased.
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